Boston Life Science Venture
5
30M
4
0.20
2
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Taipei. The company was established in Asia in Taiwan.
The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Boston Life Science Venture performs on 38 percentage points more the average number of lead investments. The important activity for fund was in 2007. The top amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Boston Life Science Venture, startups are often financed by Pacific Venture Group, Novartis Venture Fund, HealthCare Ventures. The meaningful sponsors for the fund in investment in the same round are Eminent Venture Capital, YFY Biotech Management Company, Wexford Capital. In the next rounds fund is usually obtained by Roche Venture Fund, Pacific Venture Group, HBM Healthcare Investments AG.
Among the various public portfolio startups of the fund, we may underline GlobeImmune, Nereus Pharmaceuticals, ConforMIS The fund has no exact preference in some founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Medical Device. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The overall number of key employees were 1.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (4)
- Therapeutics (4)
- Health Care (2)
- Medical (2)
- Biopharma (2) Show 1 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bayhill Therapeutics | 04 May 2005 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 35M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.